In contrast to HDACi, natural or semisynthetic protein kinase C (PKC) activators, could strongly reactivate HIV in cell line models and primary CD4+ T cells without inducing tumor formation17, 25, 26, 27. The gene discussed is PRRT2; the disease is neoplasm.